Drug–drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1)-Reference-Cited by-同舟云学术

Drug–drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1)

Published:2007-10 Issue:19-20 Volume:12 Page:838-843
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Aszalos Adorjan

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference39 articles.

1. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview;Schinkel;Adv. Drug Deliv. Rev.,2003

2. Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporine;Theis;Int. J. Clin. Pharmacol. Ther.,1998

3. Digoxin–itaconazole interaction: possible mechanism;Alderman;Ann. Pharmacother.,1998

4. The interaction of the calcium antagonist RO40-5967 with digoxin;Spieman;Br. J. Clin. Pharmacol.,1995

5. Serious interaction between mibefradil and tacrolimus;Krahenbuhl;Transplantation,1998

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the Pharmacist in the Management of Polypharmacy and Drug Interactions in the Elderly Patient with Chemotherapy;Current Cancer Therapy Reviews;2024-01

2. Discovery Toxicology in Lead Optimization;The Handbook of Medicinal Chemistry;2023-02-03

3. Lubeluzole Repositioning as Chemosensitizing Agent on Multidrug-Resistant Human Ovarian A2780/DX3 Cancer Cells;Molecules;2022-11-15

4. In vitro adjuvant antitumor activity of various classes of semi-synthetic poststerone derivatives;Bioorganic Chemistry;2021-01

5. Novel Antibiotic Combinations of Diverse Subclasses for Effective Suppression of Extensively Drug-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA);International Journal of Microbiology;2020-10-29